Metastatic cancer of unknown primary in 21 dogs

被引:20
作者
Rossi, F. [1 ]
Aresu, L. [2 ]
Vignoli, M. [1 ]
Buracco, P. [3 ]
Bettini, G. [4 ]
Ferro, S. [2 ]
Gattino, F. [3 ]
Ghiani, F. [5 ]
Costantino, R. [6 ]
Ressel, L. [7 ]
Bellei, E. [8 ]
Marconato, L. [1 ]
机构
[1] Ctr Oncol Vet, Sasso Marconi, Italy
[2] Univ Padua, Dept Comparat Biomed & Nutr, Legnaro, Italy
[3] Sch Vet, Dept Anim Pathol, Grugliasco, Italy
[4] Univ Bologna, Dept Vet Med Sci, Bologna, Italy
[5] Studio Vet Associato Costa Ghiani Spallarossa, Genoa, Italy
[6] Clin Vet Orob, Bergamo, Italy
[7] Diagnost Vet Lab, Sasso Marconi, Italy
[8] Ctr Med Vet, Finale Emilia, Italy
关键词
carcinoma; dog; MCUP; metastatic cancer; prognosis; COOPERATIVE-ONCOLOGY-GROUP; PRIMARY SITE; PRIMARY ORIGIN; PRIMARY-CARCINOMA; TUMORS; MELANOMA; MALIGNANCY; DIAGNOSIS;
D O I
10.1111/vco.12011
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of this retrospective study was to describe clinical features, treatment and outcome of 21 dogs with metastatic cancer of unknown primary (MCUP), a biopsy-proven malignancy being diagnosed at a metastatic stage, in which the anatomical origin of the primary tumour cannot be detected. All dogs underwent total-body computed tomography. Signalment, type and duration of clinical signs, metastasis site, pathology results, treatment and outcome were recorded. Carcinoma was the most common diagnosis (57.1%), followed by sarcoma, melanoma and mast cell tumour. The median number of disease sites per dog was 2, with bones, lymph nodes, lungs and spleen being the most frequent metastatic locations. The median survival for all dogs was 30days. Overall, a primary site was not identified in 20 (95.2%) dogs. MCUP encompasses a variety of different pathologic entities and harbours a poor prognosis.
引用
收藏
页码:11 / 19
页数:9
相关论文
共 30 条
[1]   UNKNOWN PRIMARY-CARCINOMA - NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 657 CONSECUTIVE PATIENTS [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
HESS, KR ;
RABER, MN ;
LENZI, R ;
FROST, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1272-1280
[2]  
[Anonymous], 2008, Cancer: Principles and Practice of Oncology
[3]   Thyroid transcription factor-1 immunohistochemistry: diagnostic tool and malignancy marker in canine malignant lung tumours [J].
Bettini, G. ;
Marconato, L. ;
Morini, M. ;
Ferrari, F. .
VETERINARY AND COMPARATIVE ONCOLOGY, 2009, 7 (01) :28-37
[4]   Acanthosis nigricans in a patient with sarcoma of unknown origin [J].
Branstsch, Kay Dietmar ;
Moehrle, Matthias .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) :527-528
[5]   Carboplatin plus paclitaxel in unknown primary carcinoma: A phase II Hellenic Cooperative Oncology Group study [J].
Briasoulis, E ;
Kalofonos, H ;
Bafaloukos, D ;
Samantas, E ;
Fountzilas, G ;
Xiros, N ;
Skarlos, D ;
Christodoulou, C ;
Kosmidis, F ;
Pavlidis, N .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3101-3107
[6]   RHABDOMYOSARCOMA, PRESENTING AS DISSEMINATED MALIGNANCY FROM AN UNKNOWN PRIMARY SITE - A RETROSPECTIVE STUDY OF 10 PEDIATRIC CASES [J].
ETCUBANAS, E ;
PEIPER, S ;
STASS, S ;
GREEN, A .
MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (01) :39-44
[7]  
Greco FA, 2001, CANCER J, V7, P203
[8]   Biomarkers in veterinary cancer screening: Applications, limitations and expectations [J].
Henry, Carolyn J. .
VETERINARY JOURNAL, 2010, 185 (01) :10-14
[9]   METASTATIC ADENOCARCINOMAS OF UNKNOWN PRIMARY SITE - PROGNOSTIC VARIABLES AND TREATMENT RESULTS [J].
KAMBHU, SA ;
KELSEN, DP ;
FIORE, J ;
NIEDZWIECKI, D ;
CHAPMAN, D ;
VINCIGUERRA, V ;
ROSENBLUTH, R .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01) :55-60
[10]   Evidence for Immunosurveillance in Intestinal Premalignant Lesions [J].
Karlsson, M. ;
Lindberg, K. ;
Karlen, P. ;
Ost, A. ;
Thorn, M. ;
Winqvist, O. ;
Eberhardson, M. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 71 (05) :362-368